Paper41588902
An Overview of the Antioxidant, Anti-inflammatory, and Anticancer Effects of Statins.
Zarei F and 4 others. Anticancer Agents Med Chem, 2026. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. An Overview of the Antioxidant, Anti-inflammatory, and Anticancer Effects of Statins. Papers, record 41588902. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41588902
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | Major topic |
| Antioxidants | Major topic |
| Antineoplastic Agents | Major topic |
| Neoplasms | Major topic |
| Anti-Inflammatory Agents | Major topic |
| Anti-Inflammatory Agents, Non-Steroidal | Major topic |
| Humans | |
| Animals | |
| Cell Proliferation | |
| Drug Screening Assays, Antitumor | |
| Oxidative Stress |
Source PubMed
References182
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21067804 | Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. | Lancet | 2010 | https://conductscience.org/library/papers/21067804 | PubMed |
| 2 | 791911 | Citrinin, an inhibitor of cholesterol synthesis. | J Antibiot (Tokyo) | 1976 | https://conductscience.org/library/papers/791911 | PubMed |
| 3 | 6933445 | Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6933445 | PubMed |
| 4 | 17928595 | Long-term follow-up of the West of Scotland Coronary Prevention Study. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17928595 | PubMed |
| 5 | 15325833 | Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. | Lancet | 2004 | https://conductscience.org/library/papers/15325833 | PubMed |
| 6 | 11306519 | Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. | Circulation | 2001 | https://conductscience.org/library/papers/11306519 | PubMed |
| 7 | 11145942 | Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. | Arterioscler Thromb Vasc Biol | 2001 | https://conductscience.org/library/papers/11145942 | PubMed |
| 8 | 15645009 | Antioxidant effects of statins. | Drugs Today (Barc) | 2004 | https://conductscience.org/library/papers/15645009 | PubMed |
| 9 | 23924053 | Differential metabolic actions of specific statins: clinical and therapeutic considerations. | Antioxid Redox Signal | 2014 | https://conductscience.org/library/papers/23924053 | PubMed |
| 10 | 16054715 | Effects of statins beyond lipid lowering: potential for clinical benefits. | Int J Cardiol | 2006 | https://conductscience.org/library/papers/16054715 | PubMed |
| 11 | 24854145 | Atorvastatin improves survival of implanted stem cells in a rat model of renal ischemia-reperfusion injury. | Am J Nephrol | 2014 | https://conductscience.org/library/papers/24854145 | PubMed |
| 12 | 27035900 | Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives. | Curr Opin Neurol | 2016 | https://conductscience.org/library/papers/27035900 | PubMed |
| 13 | 21207250 | Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial. | Lipids | 2011 | https://conductscience.org/library/papers/21207250 | PubMed |
| 14 | 28721151 | Moderate-dose atorvastatin improves arterial endothelial function in patients with angina pectoris and normal coronary angiogram: a pilot study. | Arch Med Sci | 2017 | https://conductscience.org/library/papers/28721151 | PubMed |
| 15 | 24127541 | The role of oxidative stress during inflammatory processes. | Biol Chem | 2014 | https://conductscience.org/library/papers/24127541 | PubMed |
| 16 | 28969555 | Oxidative Stress and Cancer: The Role of Nrf2. | Curr Cancer Drug Targets | 2018 | https://conductscience.org/library/papers/28969555 | PubMed |
| 17 | 11932263 | Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond. | J Clin Endocrinol Metab | 2002 | https://conductscience.org/library/papers/11932263 | PubMed |
| 18 | 16126020 | Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. | Am J Cardiol | 2005 | https://conductscience.org/library/papers/16126020 | PubMed |
| 19 | 29363784 | Nutraceuticals in the management of patients with statin-associated muscle symptoms, with a note on real-world experience. | Clin Cardiol | 2018 | https://conductscience.org/library/papers/29363784 | PubMed |
| 20 | 12011277 | Statins and risk of polyneuropathy: a case-control study. | Neurology | 2002 | https://conductscience.org/library/papers/12011277 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953363 | New strategies for the treatment of tuberculosis: research progress and clinical translation in immune modulation and inflammation control. | Front Immunol | 2026 | https://conductscience.org/library/papers/42953363 | PubMed |
| 42746176 | Statins use and prognosis in lung cancer patients treated with immune checkpoint inhibitors: evidence from a meta-analysis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42746176 | PubMed |
| 42215843 | Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42215843 | PubMed |
| 42074763 | Statins and Fibrates in Age-Related Macular Degeneration: A Contemporary Clinical Narrative Review (2020-2025). | J Clin Med | 2026 | https://conductscience.org/library/papers/42074763 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BDNF | 627 | PubTator's text mining | https://conductscience.org/library/genes/627 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41588902
GET https://conductscience.org/api/papers/v1/41588902/references?page=2